Sun Pharma Advanced Research Company informs about press release

09 Nov 2022 Evaluate
Sun Pharma Advanced Research Company has informed that it enclosed press release, ‘SPARC and Sun Pharma enter into a license agreement for commercialization of phenobarbital for injection in the US’.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

134.05 -1.55 (-1.14%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 654.25
Indegene 520.25
CMS Info Systems 344.60
Sagility 52.62
Smartworks Coworking 468.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×